Jiang YZ

No ORCID on file · 3 papers in corpus
2024
Journal of hematology & oncology ·doi:10.1186/s13045-024-01551-8

Histone deacetylase (HDAC) serves as a critical molecular regulator in the pathobiology of various malignancies and have garnered attention as a viable target for therapeutic intervention. A variety of HDAC inhibitors (HDACis) have been dev…

2020
Advanced science (Weinheim, Baden-Wurttemberg, Germany) ·doi:10.1002/advs.201901728

Breast tumor initiating cells (BTICs) with ALDH+CD24-CD44+ phenotype are the most tumorigenic and invasive cell population in breast cancer. However, the molecular mechanisms are still unclear. Here, it is found that a negative immune regul…

2013
Cancer letters ·doi:10.1016/j.canlet.2013.06.026

The aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor mediates many biological processes. Herein, we investigated if 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE, an endogenous AhR ligand) r…